A new platform for ultra-high dose rate radiobiological research using the BELLA PW laser proton beamline

A new platform for ultra-high dose rate radiobiological research using the BELLA PW laser proton beamline

Abstract Radiotherapy is the current standard of care for more than 50% of all cancer patients. Improvements in radiotherapy (RT) technology have increased tumor targeting and normal tissue sparing. Radiations at ultra-high dose rates required for FLASH-RT effects have sparked interest in potentiall...

Full description

Bibliographic Details
Main Authors: Jianhui Bin, Lieselotte Obst-Huebl, Jian-Hua Mao, Kei Nakamura, Laura D. Geulig, Hang Chang, Qing Ji, Li He, Jared De Chant, Zachary Kober, Anthony J. Gonsalves, Stepan Bulanov, Susan E. Celniker, Carl B. Schroeder, Cameron G. R. Geddes, Eric Esarey, Blake A. Simmons, Thomas Schenkel, Eleanor A. Blakely, Sven Steinke, Antoine M. Snijders
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-05181-3

Internet

https://doi.org/10.1038/s41598-022-05181-3

Similar Items